ICER and Unsupported Price Increases

The Institute for Clinical and Economic Review (ICER) recently announced that it would annually review treatments with significant price increases to determine if these changes are unsupported by evidence on value. I was recently interviewed by Radar on Specialty Pharmacy to discuss the topic. Jason Shafrin, Ph.D., a senior director of policy and economics at…

End of week links

Drug innovation and disease burden. Five lessons not learned from previous government shutdowns. “parents of daughters…become almost twice as risk-averse as parents of sons” Immigration and health care wait time in the US. Drug “kingpin captures cause large…increases to the homicide rate”

2018 Feel Good Health Stories

25 million doses of a new cholera vaccine were administered globally, and preparations began for the largest vaccination drive in history. UNICEF France revealed a sharp fall in daily smokers, with one million fewer lighting up in the past year, and cigarette use among Americans dropped to its lowest level since the Centers for Disease Control and…